Phase II Study of an Association of L-Asparaginase-Methotrexate-Dexamethasone for Relapsing and/or Refractory Nasal and Nasal-Type NK [natural killer]-T-Cell Lymphoma.

Trial Profile

Phase II Study of an Association of L-Asparaginase-Methotrexate-Dexamethasone for Relapsing and/or Refractory Nasal and Nasal-Type NK [natural killer]-T-Cell Lymphoma.

Completed
Phase of Trial: Phase II

Latest Information Update: 27 Feb 2013

At a glance

  • Drugs Asparaginase (Primary) ; Crisantaspase (Primary) ; Dexamethasone; Methotrexate
  • Indications Non-Hodgkin's lymphoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 13 Jan 2012 Planned end date changed from 1 Jun 2011 to 1 Dec 2012 as reported by ClinicalTrials.gov.
    • 03 Sep 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 06 Oct 2009 Planned number of patients changed from 30 to 40 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top